Home » BIOACCELERATE ANNOUNCES NAME CHANGE, NEW STRATEGY AND PLANNED DISTRIBUTION TO SHAREHOLDERS
BIOACCELERATE ANNOUNCES NAME CHANGE, NEW STRATEGY AND PLANNED DISTRIBUTION TO SHAREHOLDERS
Bioaccelerate Holdings, Inc today announced that it is has received majority shareholder approval
to change its name to Gardant Pharmaceuticals, Inc. The Company also announced
that it has adopted a new business strategy intended to increase overall shareholder
value.
PrimeZone
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May